The Underuse of Therapy in the Secondary Prevention of Hip Fractures

ISSN： 1170-229X

Source： Drugs & Aging, Vol.19, Iss.1, 2002-01, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet therapy in secondary stroke prevention

By Crawford K Michelle Talbert Robert L

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1609-1613

Informa Healthcare

Access to resources Recommend Favorite

Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events

By Ling Geoffrey

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 3, 2009-05 ,pp. : 197-209

Adis International

Access to resources Recommend Favorite

Extended Anticoagulation Therapy for the Primary and Secondary Prevention of Venous Thromboembolism

By Blanchard Elizabeth Ansell Jack

Drugs, Vol. 65, Iss. 3, 2005-01 ,pp. : 303-311

Adis International

Access to resources Recommend Favorite

Drug Therapy for the Secondary Prevention of Stroke in Hypertensive Patients: Current Issues and Options

By Lüders Stephan

Drugs, Vol. 67, Iss. 7, 2007-01 ,pp. : 955-963

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis

By Rosner A.J.

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 559-573

Adis International

Access to resources Recommend Favorite